# DAXXIFY

NDC: 72960-112
Generic name: botulinum toxin type A
Labeler / Manufacturer: Revance Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20220920

FDA application: BLA761127

## Active ingredients

- BOTULINUM TOXIN TYPE A: 100 U/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72960-112"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72960-112
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74